HeartBeam, Inc. (BEATW)
USD 0.51
(0.0%)
USD 0.51
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 675 Thousand USD | 105.18% |
| 2022 | -13.03 Million USD | -475.83% |
| 2021 | - USD | -187.18% |
| 2020 | -788 Thousand USD | -168.03% |
| 2019 | -294 Thousand USD | -100.32% |
| 2018 | 92.04 Million USD | 279.59% |
| 2017 | 24.24 Million USD | -19.27% |
| 2016 | 30.03 Million USD | 47.37% |
| 2015 | 20.38 Million USD | 4490.99% |
| 2014 | 444 Thousand USD | -91.48% |
| 2013 | 5.21 Million USD | 252.01% |
| 2012 | -3.43 Million USD | 93.01% |
| 2011 | -49.04 Million USD | -551.86% |
| 2010 | -7.52 Million USD | 20.98% |
| 2009 | -9.52 Million USD | -148.7% |
| 2008 | 19.55 Million USD | 366.5% |
| 2007 | 4.19 Million USD | 184.01% |
| 2006 | -4.98 Million USD | 56.48% |
| 2005 | -11.46 Million USD | 45.27% |
| 2004 | -20.94 Million USD | -65.2% |
| 2003 | -12.68 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -4.78 Million USD | 100.0% |
| 2024 Q2 | -5.09 Million USD | 0.0% |
| 2023 Q3 | -3.73 Million USD | -12.83% |
| 2023 Q2 | -3.31 Million USD | 20.31% |
| 2023 Q4 | -4.1 Million USD | -9.95% |
| 2023 FY | - USD | -17.52% |
| 2023 Q1 | -4.15 Million USD | -11.15% |
| 2022 Q3 | -3.61 Million USD | -2.12% |
| 2022 Q2 | -3.53 Million USD | -64.57% |
| 2022 Q1 | -2.14 Million USD | -60.18% |
| 2022 FY | - USD | -475.83% |
| 2022 Q4 | -3.73 Million USD | -3.57% |
| 2021 Q2 | -337 Thousand USD | -106.75% |
| 2021 Q4 | -1.34 Million USD | -200.67% |
| 2021 Q1 | -163 Thousand USD | 37.55% |
| 2021 Q3 | -446 Thousand USD | -32.34% |
| 2021 FY | - USD | -187.18% |
| 2020 Q1 | -73 Thousand USD | -100.37% |
| 2020 Q2 | -154 Thousand USD | -110.96% |
| 2020 Q3 | -272 Thousand USD | -76.62% |
| 2020 Q4 | -261 Thousand USD | 4.04% |
| 2020 FY | - USD | -168.03% |
| 2019 Q4 | 19.85 Million USD | -18.59% |
| 2019 FY | - USD | -100.32% |
| 2019 Q2 | 25.83 Million USD | 16.83% |
| 2019 Q1 | 22.11 Million USD | -12.69% |
| 2019 Q3 | 24.38 Million USD | -5.62% |
| 2018 Q1 | 17.55 Million USD | 221.46% |
| 2018 FY | - USD | 279.59% |
| 2018 Q2 | 21.68 Million USD | 23.49% |
| 2018 Q3 | 27.47 Million USD | 26.73% |
| 2018 Q4 | 25.33 Million USD | -7.81% |
| 2017 Q4 | 5.46 Million USD | -32.9% |
| 2017 Q1 | 3.04 Million USD | -53.05% |
| 2017 FY | - USD | -19.27% |
| 2017 Q2 | 6.82 Million USD | 124.01% |
| 2017 Q3 | 8.14 Million USD | 19.34% |
| 2016 Q4 | 6.48 Million USD | -19.19% |
| 2016 Q2 | 8.15 Million USD | 10.51% |
| 2016 Q1 | 7.37 Million USD | 14.91% |
| 2016 FY | - USD | 47.37% |
| 2016 Q3 | 8.02 Million USD | -1.56% |
| 2015 Q1 | 3.03 Million USD | 54.41% |
| 2015 FY | - USD | 4490.99% |
| 2015 Q4 | 6.42 Million USD | 11.07% |
| 2015 Q3 | 5.78 Million USD | 12.17% |
| 2015 Q2 | 5.15 Million USD | 70.01% |
| 2014 Q2 | -746 Thousand USD | 82.3% |
| 2014 Q3 | 3.44 Million USD | 561.26% |
| 2014 Q4 | 1.96 Million USD | -42.95% |
| 2014 FY | - USD | -91.48% |
| 2014 Q1 | -4.21 Million USD | -237.89% |
| 2013 FY | - USD | 252.01% |
| 2013 Q3 | 800 Thousand USD | 83.07% |
| 2013 Q1 | 948 Thousand USD | 153.08% |
| 2013 Q4 | 3.05 Million USD | 282.0% |
| 2013 Q2 | 437 Thousand USD | -53.9% |
| 2012 Q2 | 483 Thousand USD | 131.9% |
| 2012 Q4 | -1.78 Million USD | -95.83% |
| 2012 FY | - USD | 93.01% |
| 2012 Q1 | -1.51 Million USD | 96.77% |
| 2012 Q3 | -912 Thousand USD | -288.82% |
| 2011 FY | - USD | -551.86% |
| 2011 Q1 | 1.73 Million USD | 209.29% |
| 2011 Q2 | 439 Thousand USD | -74.62% |
| 2011 Q3 | -4.36 Million USD | -1095.22% |
| 2011 Q4 | -46.84 Million USD | -972.24% |
| 2010 FY | - USD | 20.98% |
| 2010 Q4 | -1.58 Million USD | 64.4% |
| 2010 Q3 | -4.44 Million USD | -620.12% |
| 2010 Q1 | -2.35 Million USD | 81.13% |
| 2010 Q2 | 855 Thousand USD | 136.35% |
| 2009 FY | - USD | -148.7% |
| 2009 Q4 | -12.46 Million USD | -277.27% |
| 2009 Q1 | 1.28 Million USD | -86.13% |
| 2009 Q2 | 4.96 Million USD | 285.85% |
| 2009 Q3 | -3.3 Million USD | -166.59% |
| 2008 Q2 | 4.74 Million USD | 259.28% |
| 2008 Q4 | 9.27 Million USD | 129.4% |
| 2008 FY | - USD | 366.5% |
| 2008 Q1 | 1.32 Million USD | 123.12% |
| 2008 Q3 | 4.04 Million USD | -14.9% |
| 2007 Q1 | -1.96 Million USD | 27.28% |
| 2007 Q3 | 1.78 Million USD | 190.89% |
| 2007 Q4 | -5.71 Million USD | -420.04% |
| 2007 Q2 | -1.96 Million USD | 0.0% |
| 2007 FY | - USD | 184.01% |
| 2006 Q3 | -1.64 Million USD | 24.27% |
| 2006 FY | - USD | 56.48% |
| 2006 Q4 | -2.7 Million USD | -64.1% |
| 2006 Q2 | -2.17 Million USD | 0.0% |
| 2006 Q1 | -2.17 Million USD | 0.0% |
| 2005 FY | - USD | 45.27% |
| 2004 FY | - USD | -65.2% |
| 2003 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CareCloud, Inc. | -31.29 Million USD | 102.157% |
| Augmedix, Inc. | -17.68 Million USD | 103.818% |
| BrightSpring Health Services, Inc. Common Stock | 349.51 Million USD | 99.807% |
| CareCloud, Inc. | -31.29 Million USD | 102.157% |
| HealthEquity, Inc. | 282.41 Million USD | 99.761% |
| iCoreConnect Inc. | -11.87 Million USD | 105.682% |
| Inovalon Holdings, Inc. | 186.56 Million USD | 99.638% |
| Nutex Health, Inc. | -14.58 Million USD | 104.629% |
| Omnicell, Inc. | 60.69 Million USD | 98.888% |
| OneMedNet Corporation | -11.97 Million USD | 105.639% |
| Progyny, Inc. | 64.46 Million USD | 98.953% |
| Renalytix Plc | -28.52 Million USD | 102.367% |
| Schrödinger, Inc. | -171.89 Million USD | 100.393% |
| Simulations Plus, Inc. | 6.13 Million USD | 88.99% |
| SOPHiA GENETICS SA | -70.7 Million USD | 100.955% |
| Streamline Health Solutions, Inc. | -12.81 Million USD | 105.267% |
| Ontrak, Inc. | -14.41 Million USD | 104.682% |
| GE HealthCare Technologies Inc. | 3.56 Billion USD | 99.981% |
| Sharecare, Inc. | -67.25 Million USD | 101.004% |
| Aclarion, Inc. | -4.14 Million USD | 116.303% |
| CareMax, Inc. | -590.46 Million USD | 100.114% |
| Bullfrog AI Holdings, Inc. Common Stock | -5.27 Million USD | 112.796% |
| Forian Inc. | 2.75 Million USD | 75.457% |
| Bullfrog AI Holdings, Inc. Warrants | -5.27 Million USD | 112.796% |
| GeneDx Holdings Corp. | -136.46 Million USD | 100.495% |
| SCWorx Corp. | -3.97 Million USD | 116.982% |
| Minerva Surgical, Inc. | -20.07 Million USD | 103.363% |
| Definitive Healthcare Corp. | -241.22 Million USD | 100.28% |
| 10x Genomics, Inc. | -205.11 Million USD | 100.329% |
| Zhongchao Inc. | -4.9 Million USD | 113.769% |
| Accolade, Inc. | -71.19 Million USD | 100.948% |
| MSP Recovery, Inc. | -69.22 Million USD | 100.975% |
| R1 RCM Inc. | 426.2 Million USD | 99.842% |
| Spok Holdings, Inc. | 26.29 Million USD | 97.433% |
| Privia Health Group, Inc. | 27.18 Million USD | 97.517% |
| EUDA Health Holdings Limited | -8.3 Million USD | 108.132% |
| TruBridge, Inc. | -15.39 Million USD | 104.386% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 349.51 Million USD | 99.807% |
| Sharecare, Inc. | -67.25 Million USD | 101.004% |
| Health Catalyst, Inc. | -66.46 Million USD | 101.016% |
| GoodRx Holdings, Inc. | 108.82 Million USD | 99.38% |
| Premier, Inc. | 286.08 Million USD | 99.764% |
| HealthStream, Inc. | 59.58 Million USD | 98.867% |
| Certara, Inc. | 23.84 Million USD | 97.169% |
| GeneDx Holdings Corp. | -136.46 Million USD | 100.495% |
| Ontrak, Inc. | -14.41 Million USD | 104.682% |
| SHL Telemedicine Ltd. | 3.28 Million USD | 79.443% |
| CareCloud, Inc. | -31.29 Million USD | 102.157% |
| EUDA Health Holdings Limited | -8.3 Million USD | 108.132% |
| HeartBeam, Inc. | 675 Thousand USD | 0.0% |
| Mangoceuticals, Inc. | -9.18 Million USD | 107.347% |
| CareMax, Inc. | -590.46 Million USD | 100.114% |
| Healthcare Triangle, Inc. | -4.1 Million USD | 116.447% |
| National Research Corporation | 45.98 Million USD | 98.532% |
| Aclarion, Inc. | -4.14 Million USD | 116.303% |
| OptimizeRx Corporation | -21.3 Million USD | 103.168% |